Literature DB >> 22917844

Priorities for autism spectrum disorder risk communication and ethics.

Michael Yudell1, Holly K Tabor, Geraldine Dawson, John Rossi, Craig Newschaffer.   

Abstract

Autism spectrum disorders are an issue of increasing public health significance. The incidence of autism spectrum disorders has been increasing in recent years, and they are associated with significant personal and financial impacts for affected persons and their families. In recent years, a large number of scientific studies have been undertaken, which investigate genetic and environmental risk factors for autism, with more studies underway. At present, much remains unknown regarding autism spectrum disorder risk factors, but the emerging picture of causation is in many cases complex, with multiple genes and gene-environment interactions being at play. The complexity and uncertainty surrounding autism spectrum disorder risk factors raise a number of questions regarding the ethical considerations that should be taken into account when undertaking autism spectrum disorder risk communication. At present, however, little has been written regarding autism spectrum disorder risk communication and ethics. This article summarizes the findings of a recent conference investigating ethical considerations and policy recommendations in autism spectrum disorder risk communication, which to the authors' knowledge is the first of its kind. Here, the authors discuss a number of issues, including uncertainty; comprehension; inadvertent harm; justice; and the appropriate roles of clinicians, scientists, and the media in autism spectrum disorder risk communication.

Entities:  

Keywords:  autism; ethics; risk communication

Mesh:

Year:  2012        PMID: 22917844     DOI: 10.1177/1362361312453511

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  9 in total

1.  Parents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders.

Authors:  Marian Reiff; Ellen Giarelli; Barbara A Bernhardt; Ebony Easley; Nancy B Spinner; Pamela L Sankar; Surabhi Mulchandani
Journal:  J Autism Dev Disord       Date:  2015-10

2.  Vaccine Hesitancy and Illness Perceptions: Comparing Parents of Children with Autism Spectrum Disorder to other Parent Groups.

Authors:  Leila C Sahni; Julie A Boom; Sarah S Mire; Leandra N Berry; Lauren R Dowell; Charles G Minard; Rachel M Cunningham; Robin P Goin-Kochel
Journal:  Child Health Care       Date:  2020-03-17

3.  "Set in Stone" or "Ray of Hope": Parents' Beliefs About Cause and Prognosis After Genomic Testing of Children Diagnosed with ASD.

Authors:  Marian Reiff; Eva Bugos; Ellen Giarelli; Barbara A Bernhardt; Nancy B Spinner; Pamela L Sankar; Surabhi Mulchandani
Journal:  J Autism Dev Disord       Date:  2017-05

4.  In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.

Authors:  Nicole B Gidaya; Brian K Lee; Igor Burstyn; Michael Yudell; Erik L Mortensen; Craig J Newschaffer
Journal:  J Autism Dev Disord       Date:  2014-10

5.  Commentary: Attention to Eyes Is Present but in Decline in 2-6-Month-Old Infants Later Diagnosed with Autism.

Authors:  Jennifer C Sarrett; Karen S Rommelfanger
Journal:  Front Public Health       Date:  2015-12-08

Review 6.  Ethical issues in genomics research on neurodevelopmental disorders: a critical interpretive review.

Authors:  S Mezinska; L Gallagher; M Verbrugge; E M Bunnik
Journal:  Hum Genomics       Date:  2021-03-12       Impact factor: 4.639

Review 7.  Annual Research Review: Shifting from 'normal science' to neurodiversity in autism science.

Authors:  Elizabeth Pellicano; Jacquiline den Houting
Journal:  J Child Psychol Psychiatry       Date:  2021-11-03       Impact factor: 8.265

8.  Views on researcher-community engagement in autism research in the United Kingdom: a mixed-methods study.

Authors:  Elizabeth Pellicano; Adam Dinsmore; Tony Charman
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

9.  Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.

Authors:  Michael G Aman; Robert L Findling; Antonio Y Hardan; Robert L Hendren; Raun D Melmed; Ola Kehinde-Nelson; Hai-An Hsu; Joel M Trugman; Robert H Palmer; Stephen M Graham; Allyson T Gage; James L Perhach; Ephraim Katz
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-03-15       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.